{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:55:32Z","timestamp":1788368132018,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Ethiopia, by the end of 2018, an estimated 690,000 people are infected with HIV and the annual cases of Visceral Leishmaniasis (VL) is estimated to be between 4000 and 5000 with over 3.2 million people are at risk. Northwest Ethiopia accounts for over 60% cases of VL in the country. Prevalence of HIV infection among VL infected people in Ethiopia has not yet been synthesized. Therefore, we aimed to estimate the pooled prevalence of HIV infection among VL infected people in Northwest Ethiopia with the hope that it would guide the development of a more robust and cost-effective intervention strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this systematic review and meta-analysis, we searched six international databases: PubMed, Ovid MEDLINE\u00ae, Embase, Scopus, Google Scholar, and ProQuest Dissertations &amp; Theses. We also searched reference lists of included studies and Ethiopian universities electronic thesis and dissertation repositories. The search was performed until June 30,2019. Funnel plot symmetry visualization confirmed by Egger\u2019s regression asymmetry test and Begg rank correlation methods was used to assess publication bias. Pooled prevalence estimate was calculated using Der Simonian and Laird\u2019s random Effects model. We went further to perform univariate meta-regression and subgroup analysis to identify a possible sources of heterogeneity among the studies. STATA software (version 14, Texas, USA) was used for analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From 1286 citations identified by our search, 19 relevant studies with 5355 VL infected individuals were included in this meta-analysis. The pooled prevalence of HIV infection among VL infected individuals in Northwest Ethiopia was 24% (95%CI: 17\u201330%). The result of sensitivity analysis demonstrated that the pooled prevalence estimate was robust and not one-study dependent. The pooled prevalence estimate of HIV infection among VL infected people in Northwest Ethiopia ranged from 20.88% (95%CI: 15.91\u201325.86) to 24.86% (95%CI: 18.57\u201331.14) after a single study was deleted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The burden of HIV infection in people infected with VL in Northwest Ethiopia is considerably high. Integrating HIV\/AIDS surveillance among VL infected people would improve case detection as well as prevention and control of disease spread.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-4935-x","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:03:08Z","timestamp":1584018188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence estimates of human immunodeficiency virus (HIV) infection among visceral leishmaniasis infected people in Northwest Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Mehdi","family":"Mohebali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Yimam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"issue":"2","key":"4935_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1590\/S0074-02762001000200005","volume":"96","author":"FJ Andrade-Narv\u00e1ez","year":"2001","unstructured":"Andrade-Narv\u00e1ez FJ, Vargas-Gonz\u00e1lez A, Canto-Lara SB, Dami\u00e1n-Centeno AG. Clinical picture of cutaneous leishmaniases due to Leishmania (Leishmania) mexicana in the Yucatan peninsula. Mexico Mem\u00f3rias do Instituto Oswaldo Cruz. 2001;96(2):163\u20137.","journal-title":"Mexico Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"4935_CR2","unstructured":"Alan DT, Barrett LR. Stanberry. Vaccines for biodefense and emerging and neglected diseases. Amsterdam: Elsevier BV; 2009. eBook ISBN: 9780080919027."},{"issue":"1","key":"4935_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/bmb\/lds031","volume":"104","author":"M Barrett","year":"2012","unstructured":"Barrett M, Croft S. Management of trypanosomiasis and leishmaniasis. Br Med Bull. 2012;104(1):175\u201396.","journal-title":"Br Med Bull"},{"issue":"9","key":"4935_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin J-C, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"4935_CR5","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, Team WLC. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.","journal-title":"PLoS One"},{"issue":"1","key":"4935_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0035-9203(01)90320-7","volume":"95","author":"EE Bejarano","year":"2001","unstructured":"Bejarano EE, Uribe S, Rojas W, Dar\u00efo V\u00e9lez I. Presence of Lutzomyia evansi, a vector of American visceral leishmaniasis, in an urban area of the Colombian Caribbean coast. Trans R Soc Trop Med Hyg. 2001;95(1):27\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4935_CR7","unstructured":"World Health Organization: Leishmaniasis. Available at\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed 23 July 2019."},{"issue":"3","key":"4935_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12288-010-0027-1","volume":"26","author":"N Varma","year":"2010","unstructured":"Varma N, Naseem S. Hematologic changes in visceral leishmaniasis\/kala azar. Indian J Hematol Blood Transfus. 2010;26(3):78\u201382.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"5","key":"4935_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1086\/381203","volume":"38","author":"S Collin","year":"2004","unstructured":"Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, Kipngetich S, Davies C. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis. 2004;38(5):612\u20139.","journal-title":"Clin Infect Dis"},{"key":"4935_CR10","unstructured":"WHO: Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010, vol. 949: World Health Organization; 2010."},{"issue":"4","key":"4935_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4269\/ajtmh.2011.10-0321","volume":"84","author":"MO Harhay","year":"2011","unstructured":"Harhay MO, Olliaro PL, Vaillant M, Chappuis F, Lima MA, Ritmeijer K, Costa CH, Costa DL, Rijal S, Sundar S. Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am J Trop Med Hyg. 2011;84(4):543\u201350.","journal-title":"Am J Trop Med Hyg"},{"key":"4935_CR12","doi-asserted-by":"crossref","unstructured":"Cole A, Cosgrove P, Robinson G. A preliminary report of an outbreak of Kala-Azar in a Battalion of King's African Rifles. Trans R Soc Trop Med Hyg. 1942;36(1):25-34.","DOI":"10.1016\/S0035-9203(42)90053-1"},{"issue":"1","key":"4935_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trstmh.2005.07.003","volume":"100","author":"A Hailu","year":"2006","unstructured":"Hailu A, Schoone GJ, Diro E, Tesfaye A, Techane Y, Tefera T, Assefa Y, Genetu A, Kebede Y, Kebede T, et al. Field evaluation of a fast anti-Leishmania antibody detection assay in Ethiopia. Trans R Soc Trop Med Hyg. 2006;100(1):48\u201352. https:\/\/doi.org\/10.1016\/j.trstmh.2005.07.003.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"4935_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1756-3305-5-240","volume":"5","author":"K Deribe","year":"2012","unstructured":"Deribe K, Meribo K, Gebre T, Hailu A, Ali A, Aseffa A, Davey G. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasites Vectors. 2012;5(1):240. https:\/\/doi.org\/10.1186\/1756-3305-5-240.","journal-title":"Parasites Vectors"},{"issue":"8","key":"4935_CR15","doi-asserted-by":"publisher","first-page":"e3021","DOI":"10.1371\/journal.pntd.0003021","volume":"8","author":"B Monge-Maillo","year":"2014","unstructured":"Monge-Maillo B, Norman FF, Cruz I, Alvar J, L\u00f3pez-V\u00e9lez R. Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region. PLOS Negl Trop Dis. 2014;8(8):e3021. https:\/\/doi.org\/10.1371\/journal.pntd.0003021.","journal-title":"PLOS Negl Trop Dis"},{"issue":"4","key":"4935_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5123\/S1679-49742011000400011","volume":"20","author":"S-G MLd","year":"2011","unstructured":"MLd S-G, ANS M-E, Pelissari DM. Lima Junior FEFd, Sena JMd, Cechinel MP: Coinfec\u00e7\u00e3o Leishmania-HIV no Brasil: aspectos epidemiol\u00f3gicos, cl\u00ednicos e laboratoriais. Epidemiologia e Servi\u00e7os de Sa\u00fade. 2011;20(4):519\u201326.","journal-title":"Epidemiologia e Servi\u00e7os de Sa\u00fade"},{"key":"4935_CR17","volume-title":"Manual on case management and surveillance of the leishmaniases in the WHO European region","author":"L Gradoni","year":"2017","unstructured":"Gradoni L, L\u00f3pez-V\u00e9lez R, Mokni M. Manual on case management and surveillance of the leishmaniases in the WHO European region. Copenhagen: World Health Organization; 2017."},{"issue":"6","key":"4935_CR18","doi-asserted-by":"publisher","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","volume":"8","author":"E Diro","year":"2014","unstructured":"Diro E, Lynen L, Ritmeijer K, Boelaert M, Hailu A, van Griensven J. Visceral Leishmaniasis and HIV coinfection in East Africa. PLoS Negl Trop Dis. 2014;8(6):e2869. https:\/\/doi.org\/10.1371\/journal.pntd.0002869.","journal-title":"PLoS Negl Trop Dis"},{"issue":"sup1","key":"4935_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/000349803225002499","volume":"97","author":"P Desjeux","year":"2003","unstructured":"Desjeux P, Alvar J. Leishmania\/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97(sup1):3\u201315.","journal-title":"Ann Trop Med Parasitol"},{"key":"4935_CR20","unstructured":"Cruz I, Nieto J, Moreno J, Ca\u00f1avate C, Desjeux P, Alvar J. Leishmania\/HIV co-infections in the second decade. Indian J Med Res. 2006;123(3):357-88."},{"key":"4935_CR21","unstructured":"World Health Organization. Leishmaniasis: Leishmaniasis and HIV coinfection. Available at\u00a0https:\/\/www.who.int\/leishmaniasis\/burden\/hiv_coinfection\/burden_hiv_coinfection\/en\/. Accessed 30 July 2019."},{"key":"4935_CR22","unstructured":"World Health Organization. HIV\/AIDS progress in 2014: Update\/Ethiopia. Available at\u00a0https:\/\/www.afro.who.int\/sites\/default\/files\/2017-05\/ethiopia_update-sheet-on-hiv%2D%2D-aids-programme_2014_final.pdf. Accessed 3 Aug 2019."},{"issue":"1","key":"4935_CR23","first-page":"53","volume":"21","author":"G Mengistu","year":"2007","unstructured":"Mengistu G, Ayele B. Visceral Lieshmaniasis and HIV co-infection in patients admitted to Gondar University hospital, Northwest Ethiopia. Ethiop J Health Dev. 2007;21(1):53\u201360.","journal-title":"Ethiop J Health Dev"},{"issue":"11","key":"4935_CR24","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/j.1365-3156.2010.02623.x","volume":"15","author":"Z Hurissa","year":"2010","unstructured":"Hurissa Z, Cuevas LE, Lalloo DG, Hailu A. Letters to the Editors. Trop Med Int Health. 2010;15(11):1401. https:\/\/doi.org\/10.1111\/j.1365-3156.2010.02623.x.","journal-title":"Trop Med Int Health"},{"key":"4935_CR25","doi-asserted-by":"publisher","unstructured":"Diro E, Lynen L, Gebregziabiher B, Assefa A, Lakew W, Belew Z, Hailu A, Boelaert M, Griensven J: Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia. Trop Med Int Health 2015, 20(1):http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1111\/tmi.12407: 8-16.","DOI":"10.1111\/tmi.12407"},{"issue":"12","key":"4935_CR26","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1093\/cid\/cir674","volume":"53","author":"K Ritmeijer","year":"2011","unstructured":"Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, Davidson RN. Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. Clin Infect Dis : Official Publication Infect Dis Soc Am. 2011;53(12):e152\u20138. https:\/\/doi.org\/10.1093\/cid\/cir674.","journal-title":"Clin Infect Dis : Official Publication Infect Dis Soc Am"},{"issue":"4","key":"4935_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"4935_CR28","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R: Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012, 65(9):https:\/\/doi.org\/10.1016\/j.jclinepi.2011.11.014: 934\u2013939."},{"key":"4935_CR29","doi-asserted-by":"publisher","unstructured":"Alemayehu M, Wubshet M, Mesfin N, Gebayehu A. Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study. PLoS Negl Trop Dis. 2017;17, 152(1). https:\/\/doi.org\/10.1371\/journal.pntd.000542010.1186\/s12879-017-2261-8.","DOI":"10.1371\/journal.pntd.000542010.1186\/s12879-017-2261-8"},{"key":"4935_CR30","unstructured":"Bantie K, Tessema F, Massa D, Tafere Y. Factors associated with visceral leishmaniasis infection in the North Gondar zone, Amhara region, North West Ethiopia, case-control study. Sci J Pub Health. 2014;2(6):560\u20138."},{"key":"4935_CR31","unstructured":"Beshah AM. Clinical manifestations and anthropometric profiles of visceral leishmaniasis in selected centers in Ethiopia. Dissertation. South Africa: University of South Africa; 2011."},{"key":"4935_CR32","doi-asserted-by":"publisher","unstructured":"Endris M, Takele Y, Woldeyohannes D, Tiruneh M, Mohammed R, Moges F. Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia. 2014;2014:361058. https:\/\/doi.org\/10.1155\/2014\/361058.","DOI":"10.1155\/2014\/361058"},{"issue":"1","key":"4935_CR33","doi-asserted-by":"publisher","first-page":"e0006988","DOI":"10.1371\/journal.pntd.0006988","volume":"13","author":"E Diro","year":"2019","unstructured":"Diro E, Blesson S, Edwards T, Ritmeijer K, Fikre H, Admassu H, Kibret A, Ellis SJ, Bardonneau C, Zijlstra EE. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. PLoS Negl Trop Dis. 2019;13(1):e0006988.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"4935_CR34","doi-asserted-by":"publisher","first-page":"e0003738","DOI":"10.1371\/journal.pntd.0003738","volume":"9","author":"E Diro","year":"2015","unstructured":"Diro E, Lynen L, Assefa M, Takele Y, Mengesha B, Adem E, Mohammed R, Kimutai R, Hailu A, Boelaert M. Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study. PLoS Negl Trop Dis. 2015;9(5):e0003738.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"4935_CR35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.trstmh.2010.07.007","volume":"104","author":"W Hailu","year":"2010","unstructured":"Hailu W, Weldegebreal T, Hurissa Z, Tafes H, Omollo R, Yifru S, Balasegaram M, Hailu A. Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection. Trans Royal Soc Trop Med Hyg. 2010;104(11):706\u201312. https:\/\/doi.org\/10.1016\/j.trstmh.2010.07.007.","journal-title":"Trans Royal Soc Trop Med Hyg"},{"issue":"3","key":"4935_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4269\/ajtmh.2009.81.373","volume":"81","author":"M Herrero","year":"2009","unstructured":"Herrero M, Orfanos G, Argaw D, Mulugeta A, Aparicio P, Parre\u00f1o F, Bernal O, Rubens D, Pedraza J, Lima MA. Natural history of a visceral leishmaniasis outbreak in highland Ethiopia. Am J Trop Med Hyg. 2009;81(3):373\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"4935_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","volume":"8","author":"S Lyons","year":"2003","unstructured":"Lyons S, Veeken H, Long J. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health : TM & IH. 2003;8(8):733\u20139.","journal-title":"Trop Med Int Health : TM & IH"},{"key":"4935_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1756-0500-7-75","volume":"7","author":"B Mengesha","year":"2014","unstructured":"Mengesha B, Endris M, Takele Y, Mekonnen K, Tadesse T, Feleke A, Diro E. Prevalence of malnutrition and associated risk factors among adult visceral leishmaniasis patients in Northwest Ethiopia: a cross sectional study. BMC Res Notes. 2014;7:75. https:\/\/doi.org\/10.1186\/1756-0500-7-75.","journal-title":"BMC Res Notes"},{"issue":"3","key":"4935_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1086\/505217","volume":"43","author":"K Ritmeijer","year":"2006","unstructured":"Ritmeijer K, Abren D, Assefa Y, Tadesse Beyene H, et al. A comparison of Miltefosine and sodium Stibogluconate for treatment of visceral Leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis. 2006;43(3):357.","journal-title":"Clin Infect Dis"},{"key":"4935_CR40","doi-asserted-by":"publisher","unstructured":"Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, Davidson RN. Ethiopian visceral leishmaniasis: Generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans Royal Soc Trop Med Hyg. 2001;95(6):668\u201372. https:\/\/doi.org\/10.1016\/S0035-9203(01)90110-5.","DOI":"10.1016\/S0035-9203(01)90110-5"},{"key":"4935_CR41","doi-asserted-by":"crossref","unstructured":"ter Horst R, Tefera T, Assefa G, Ebrahim AZ, Davidson RN, Ritmeijer K. Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia. Am J Trop Med Hyg. 2009;80(6):929\u201334.","DOI":"10.4269\/ajtmh.2009.80.929"},{"key":"4935_CR42","doi-asserted-by":"crossref","unstructured":"Welay GM, Alene KA, Dachew BA. Visceral leishmaniasis treatment outcome and its determinants in Northwest Ethiopia. Epidemiol Health. 2017;39.","DOI":"10.4178\/epih.e2017001"},{"issue":"1","key":"4935_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11648\/j.ajbls.20140201.11","volume":"2","author":"M Yimer","year":"2014","unstructured":"Yimer M, Abera B, Mulu W, Zenebe Y, Bezabih B. Proportion of visceral leishmaniasis and human immune deficiency virus co-infection among clinically confirmed visceral leishmaniasis patients at the endemic foci of the Amhara National Regional State, north-West Ethiopia. Am J Biomed Life Sci. 2014;2(1):1\u20137.","journal-title":"Am J Biomed Life Sci"},{"key":"4935_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/HIV.S143929","volume":"10","author":"JAL Lindoso","year":"2018","unstructured":"Lindoso JAL, Moreira CHV, Cunha MA, Queiroz IT. Visceral leishmaniasis and HIV coinfection: current perspectives. HIV\/AIDS (Auckland, NZ). 2018;10:193\u2013201. https:\/\/doi.org\/10.2147\/HIV.S143929.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"4935_CR45","unstructured":"Report of the Fifth Consultative Meeting on Leishmania\/HIV Coinfection [https:\/\/www.who.int\/leishmaniasis\/resources\/Leishmaniasis_hiv_coinfection5.pdf]."},{"key":"4935_CR46","unstructured":"UNAIDS data 2018 [https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/unaids-data-2018_en.pdf]."},{"key":"4935_CR47","doi-asserted-by":"publisher","unstructured":"Kassahun A, Sadlova J, Dvorak V, Kostalova T, Rohousova I, Frynta D, Aghova T, Yasur-Landau D, Lemma W, Hailu A et al: Detection of Leishmania donovani and L. tropica in Ethiopian wild rodents. Acta Tropica 2015, 145:http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.actatropica.2015.02.006: 39\u201344.","DOI":"10.1016\/j.actatropica.2015.02.006"},{"key":"4935_CR48","doi-asserted-by":"crossref","unstructured":"Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis. 2008, e313;2(10).","DOI":"10.1371\/journal.pntd.0000313"},{"key":"4935_CR49","doi-asserted-by":"publisher","unstructured":"Alvar J, Aparicio P, Aseffa A, Den Boer M, Ca\u00f1avate C, Dedet J-P, Gradoni L, Ter Horst R, L\u00f3pez-V\u00e9lez R, Moreno J: The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008, 21(2):http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1128\/CMR.00061-07: 334-359, table of contents.","DOI":"10.1128\/CMR.00061-07"},{"issue":"3","key":"4935_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3920\/WMJ2008.x036","volume":"1","author":"H Abbas","year":"2008","unstructured":"Abbas H, Zablotowicz R, Bruns H. Modelling the colonisation of maize by toxigenic and non-toxigenic Aspergillus flavus strains: implications for biological control. World Mycotoxin J. 2008;1(3):333\u201340.","journal-title":"World Mycotoxin J"},{"key":"4935_CR51","doi-asserted-by":"crossref","unstructured":"Lemma W, Tekie H, Yared S, Balkew M, Gebre-Michael T, Warburg A, Hailu A. Sero-prevalence of Leishmania donovani infection in labour migrants and entomological risk factors in extra-domestic habitats of Kafta-Humera lowlands-kala-azar endemic areas in the Northwest Ethiopia. BMC Infect Dis. 2015;15(1):99. Page 1-8.","DOI":"10.1186\/s12879-015-0830-2"},{"issue":"1","key":"4935_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40249-019-0594-9","volume":"8","author":"GD Kibret","year":"2019","unstructured":"Kibret GD, Ferede A, Leshargie CT, Wagnew F, Ketema DB, Alebel A. Trends and spatial distributions of HIV prevalence in Ethiopia. Infect Dis Poverty. 2019;8(1):90.","journal-title":"Infect Dis Poverty"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4935-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:10:46Z","timestamp":1615507846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4935-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4935"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4935-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"14 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}